https://www.nuaxia.com/zh/post/fda-approves-pasatru-as-second-treatment-for-fibrodysplasia-ossificans-progressiva-1
FDA approves Pasatru as second treatment for fibrodysplasia ossificans progressiva
Aug 20, 2026 - The approval provides adults with fibrodysplasia ossificans progressiva with a new treatment option designed to reduce abnormal bone formation and disease...
fdaapprovespasatrusecondtreatment